Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Gottlieb

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Nature Biotechnology|August 11, 2006
A regulatory perspective on in vitro diagnosticsScott Gottlieb, Janet Woodcock
The New England Journal of Medicine|August 17, 2017
A Nicotine-Focused Framework for Public HealthScott Gottlieb, Mitchell Zeller
JAMA Health Forum|March 26, 2026
FDA's Promising New Framework for Rare Genetic DiseasesScott Gottlieb, Maarika Kimbrell
JAMA Health Forum|June 8, 2023
Regulators Face Novel Challenges as Artificial Intelligence Tools Enter Medical PracticeScott Gottlieb, Lauren Silvis
American Journal of Preventive Medicine|December 1, 2012
A role for entrepreneurs: an observation on lowering healthcare costs via technology innovationScott Gottlieb, Josh Makower
JAMA|July 9, 2017
Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse EpidemicScott Gottlieb, Janet Woodcock
JAMA Health Forum|September 21, 2023
How to Safely Integrate Large Language Models Into Health CareScott Gottlieb, Lauren Silvis
JAMA Health Forum|October 13, 2022
Reforms Needed to Modernize the US Food and Drug Administration's Oversight of Dietary Supplements, Cosmetics, and Diagnostic TestsScott Gottlieb, Mark B McClellan
The New England Journal of Medicine|August 16, 2018
The Next Phase of Human Gene-Therapy OversightFrancis S Collins, Scott Gottlieb
JAMA Health Forum|May 8, 2025
Why a Planned Reorganization of the FDA Creates Major ChallengesScott Gottlieb, Mark B McClellan
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Nature Biotechnology|August 11, 2006
A regulatory perspective on in vitro diagnosticsScott Gottlieb, Janet Woodcock
The New England Journal of Medicine|August 17, 2017
A Nicotine-Focused Framework for Public HealthScott Gottlieb, Mitchell Zeller
JAMA Health Forum|March 26, 2026
FDA's Promising New Framework for Rare Genetic DiseasesScott Gottlieb, Maarika Kimbrell
JAMA Health Forum|June 8, 2023
Regulators Face Novel Challenges as Artificial Intelligence Tools Enter Medical PracticeScott Gottlieb, Lauren Silvis
American Journal of Preventive Medicine|December 1, 2012
A role for entrepreneurs: an observation on lowering healthcare costs via technology innovationScott Gottlieb, Josh Makower
JAMA|July 9, 2017
Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse EpidemicScott Gottlieb, Janet Woodcock
JAMA Health Forum|September 21, 2023
How to Safely Integrate Large Language Models Into Health CareScott Gottlieb, Lauren Silvis
JAMA Health Forum|October 13, 2022
Reforms Needed to Modernize the US Food and Drug Administration's Oversight of Dietary Supplements, Cosmetics, and Diagnostic TestsScott Gottlieb, Mark B McClellan
The New England Journal of Medicine|August 16, 2018
The Next Phase of Human Gene-Therapy OversightFrancis S Collins, Scott Gottlieb
JAMA Health Forum|May 8, 2025
Why a Planned Reorganization of the FDA Creates Major ChallengesScott Gottlieb, Mark B McClellan
Pageof 9